Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-10
SponsorChildren's Hospital of Soochow University

About this trial

Childhood obesity has become a major global public health challenge. Obesity can not only affects children's physical and mental health during childhood but may also persist into adulthood, significantly increasing the risk of cardiovascular disease. Therefore, effective prevention and control of childhood obesity can shift the prevention window forward and promote the prevention of cardiovascular disease. Recently, time-restricted eating (TRE) has gained attention in adult studies for its feasibility, as it involves "time control without calorie restriction," demonstrating weight loss effects comparable to energy restriction and higher feasibility. Here, the investigators designed a school-based cluster randomized controlled trial to investigate the effectiveness of 12-hour TRE in preventing and controlling childhood obesity. Schools were randomly assigned to either the intervention group or the control group, and participants were recruited from each school at the class level, ensuring that each group included at least 690 children. The control group received routine health education, while the intervention group received 12-hour TRE in addition to routine health education. After a 9-month intervention period (one academic year), the two groups will be compared in terms of weight management and childhood obesity prevalence.

Eligibility criteria

Qualifiers

The principal agrees to accept the randomization process and adhere to the study protocol;

The total number of fourth-year students in the school must be more than 50;

Schools that have not implemented or plan to implement obesity prevention interventions;

Non-boarding schools, Ethnic minority schools, or specialty schools;

Disqualifiers

Individuals with a history of heart disease, high blood pressure, diabetes, tuberculosis, asthma, hepatitis or nephritis;

Individuals with secondary obesity: obesity due to endocrine disorders or side effects of medications;

Individuals with abnormal growth and development, such as dwarfism, gigantism, etc;

Individuals with physical deformities, including severe scoliosis, chicken breasts, claudication, significant O-leg/X-shaped legs;

Trial design

Treatments tested in this trial

  • 12-hour time-restricted eating
  • health education

Treatment groups

1,380 Participants
are divided into 2 treatment groups

Sponsors and collaborators